Abu Saleh Md Moin
Hypoglycaemia in type 2 diabetes exacerbates amyloid-related proteins associated with dementia
Moin, Abu Saleh Md; Al-Qaissi, Ahmed; Sathyapalan, Thozhukat; Atkin, Stephen L.; Butler, Alexandra E.
Authors
Ahmed Al-Qaissi
Thozhukat Sathyapalan
Stephen L. Atkin
Alexandra E. Butler
Abstract
Objective
Hypoglycemia in diabetes (T2D) may increase the risk for Alzheimer's disease (AD). We hypothesized that hypoglycemia‐induced amyloid‐related protein changes would be exacerbated in T2D.
Methods
A prospective, parallel study in T2D (n=23) and controls (n=23). Subjects underwent insulin‐induced hypoglycemia with blood sampling at baseline, hypoglycemia and post‐hypoglycemia; proteomic analysis of amyloid‐related proteins was undertaken.
Results
At baseline: Amyloid‐precursor protein (APP) (p
Citation
Moin, A. S. M., Al-Qaissi, A., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (in press). Hypoglycaemia in type 2 diabetes exacerbates amyloid-related proteins associated with dementia. Diabetes, Obesity and Metabolism, https://doi.org/10.1111/dom.14220
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 4, 2020 |
Online Publication Date | Oct 7, 2020 |
Deposit Date | Oct 13, 2020 |
Publicly Available Date | Oct 8, 2021 |
Journal | Diabetes, Obesity and Metabolism |
Print ISSN | 1462-8902 |
Electronic ISSN | 1463-1326 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1111/dom.14220 |
Keywords | Type 2 diabetes; Hypoglycemia; Dementia; Alzheimer's disease; Amyloid‐related proteins |
Public URL | https://hull-repository.worktribe.com/output/3633660 |
Publisher URL | https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14220 |
Additional Information | Received: 2020-08-19; Accepted: 2020-10-04; Published: 2020-10-07 |
Files
This file is under embargo until Oct 8, 2021 due to copyright reasons.
Contact T.Sathyapalan@hull.ac.uk to request a copy for personal use.
You might also like
The role of interleukin-18 in the development and progression of atherosclerosis
(2020)
Journal Article
Anti-inflammatory potentials of incretin-based therapies used in the management of diabetes
(2019)
Journal Article